Indication
Reversal of neuromuscular blockade induced by rocuronium
Reversal of neuromuscular blockade induced by rocuronium refers to the pharmacological restoration of normal skeletal muscle function following the administration of the non-depolarizing neuromuscular blocking agent rocuronium bromide. Read more about Reversal of neuromuscular blockade induced by rocuronium
15 drugs 15 manufacturers
Drugs that treat it
Common Reversal of neuromuscular blockade induced by rocuronium therapies.
SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonReversal of neuromuscular blockade induced by rocuronium refers to the pharmacological restoration of normal skeletal muscle function following the administration of the non-depolarizing neuromuscular blocking agent rocuronium bromide.
Rocuronium acts at the motor endplates of the peripheral nervous system by competitively binding to nicotinic acetylcholine receptors, thereby inhibiting synaptic transmission and causing temporary flaccid paralysis.
This therapeutic state is induced during surgical procedures or mechanical ventilation to facilitate endotracheal intubation and optimize operating conditions.
Reversal is indicated in postoperative or post-procedural settings to terminate residual muscle paralysis, restore spontaneous respiration, and safeguard against critical complications such as hypoventilation, airway collapse, and aspiration.
- nih.gov
Reversal of neuromuscular blockade induced by rocuronium refers to the pharmacological restoration of normal skeletal muscle function following the administration of the non-depolarizing neuromuscular blocking agent rocuronium bromide
- theoncologynurse.com
Reversal of neuromuscular blockade induced by rocuronium refers to the pharmacological restoration of normal skeletal muscle function following the administration of the non-depolarizing neuromuscular blocking agent rocuronium bromide Rocuronium acts at the motor endplates of the peripheral nervous system by competitively binding to nicotinic acetylcholine receptors, thereby inhibiting synaptic transmission and causing temporary flaccid paralysis This therapeutic state is induced during surgical...
- nih.gov
Reversal of neuromuscular blockade induced by rocuronium refers to the pharmacological restoration of normal skeletal muscle function following the administration of the non-depolarizing neuromuscular blocking agent rocuronium bromide Rocuronium acts at the motor endplates of the peripheral nervous system by competitively binding to nicotinic acetylcholine receptors, thereby inhibiting synaptic transmission and causing temporary flaccid paralysis This therapeutic state is induced during surgical...
- columbusanesthesiaservices.com
Rocuronium acts at the motor endplates of the peripheral nervous system by competitively binding to nicotinic acetylcholine receptors, thereby inhibiting synaptic transmission and causing temporary flaccid paralysis
- fda.gov
This therapeutic state is induced during surgical procedures or mechanical ventilation to facilitate endotracheal intubation and optimize operating conditions
- nih.gov
Reversal is indicated in postoperative or post-procedural settings to terminate residual muscle paralysis, restore spontaneous respiration, and safeguard against critical complications such as hypoventilation, airway collapse, and aspiration
Personalize your experience
Follow Reversal of neuromuscular blockade induced by rocuronium and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.